Munafa Stock Market Course + Intraday & FNO calls 
Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Lexicon Pharmaceuticals (LXRX)
Technical Analysis Report for USA stock LXRX Lexicon Pharmaceuticals. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock LXRX Lexicon Pharmaceuticals then click here. or read Experts views on Lexicon Pharmaceuticals or Forecast & share price targets of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals Opened at 1.24 and Closed at: 1.23, which is 0% of previous session's close. It moved within a range of 1.19 and 1.24
The session was a Bearish session with an average volume of 818869, which is 8.65% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 1.19 and resistance for tomorrow is 1.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.2, 1.17 resistance for tomorrow's hourly charts is 1.25, 1.27
10 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.21 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.29 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.36 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.3 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Lexicon Pharmaceuticals is 1.01 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Lexicon Pharmaceuticals is at 1.29 and 200 DMA is at 1.01, while 50 DMA and 100 DMA are at 1.36 and 1.3 respectively
Lexicon Pharmaceuticals (LXRX) moving average of 20 SMA is at 1.29 and 20 EMA is at 1.28
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Fri Dec | 1.23 | 1.29 | 1.28 |
| 24 Wed Dec | 1.23 | 1.3 | 1.28 |
| 23 Tue Dec | 1.21 | 1.31 | 1.28 |
| 22 Mon Dec | 1.22 | 1.32 | 1.29 |
| 19 Fri Dec | 1.17 | 1.33 | 1.3 |
| 18 Thu Dec | 1.17 | 1.33 | 1.31 |
Lexicon Pharmaceuticals (LXRX) moving average of 50 SMA is at 1.36 and 50 EMA is at 1.31
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Fri Dec | 1.23 | 1.36 | 1.31 |
| 24 Wed Dec | 1.23 | 1.37 | 1.31 |
| 23 Tue Dec | 1.21 | 1.38 | 1.31 |
| 22 Mon Dec | 1.22 | 1.38 | 1.31 |
| 19 Fri Dec | 1.17 | 1.39 | 1.31 |
| 18 Thu Dec | 1.17 | 1.39 | 1.32 |
Lexicon Pharmaceuticals (LXRX) moving average of 100 SMA is at 1.3 and 100 EMA is at 1.22
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Fri Dec | 1.23 | 1.3 | 1.22 |
| 24 Wed Dec | 1.23 | 1.3 | 1.22 |
| 23 Tue Dec | 1.21 | 1.3 | 1.22 |
| 22 Mon Dec | 1.22 | 1.29 | 1.22 |
| 19 Fri Dec | 1.17 | 1.29 | 1.22 |
| 18 Thu Dec | 1.17 | 1.29 | 1.22 |
Lexicon Pharmaceuticals (LXRX) moving average of 200 SMA is at 1.01 and 200 EMA is at 1.07
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Fri Dec | 1.23 | 1.01 | 1.07 |
| 24 Wed Dec | 1.23 | 1.01 | 1.07 |
| 23 Tue Dec | 1.21 | 1 | 1.07 |
| 22 Mon Dec | 1.22 | 1 | 1.07 |
| 19 Fri Dec | 1.17 | 0.99 | 1.07 |
| 18 Thu Dec | 1.17 | 0.99 | 1.07 |
Teladoc Health has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Teladoc Health, about 7.93% more returns!
Edwards Lifesciences has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 14.2% more returns!
Abbvie Inc has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Abbvie Inc, about 14.99% more returns!
Dentsply Sirona has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Dentsply Sirona, about 15.58% more returns!
Trillium Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Trillium Therapeutics, about 13.21% more returns!
Bio Techne has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Bio Techne, about 5.79% more returns!
Summit Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Summit Therapeutics, about 15.39% more returns!
Si Bone has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 18.61% more returns!
Quidel Corporation has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Quidel Corporation, about 21.12% more returns!
Mannkind Corporation has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Mannkind Corporation, about 22.21% more returns!
Mesoblast has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Mesoblast, about 27.16% more returns!
Microbot Medical has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Microbot Medical, about 2.83% more returns!
Krystal Biotech has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Krystal Biotech, about 29.66% more returns!
Karyopharm Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 46.37% more returns!
Kalvista Pharmaceuticals has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 18.83% more returns!
Amicus Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Amicus Therapeutics, about 57.49% more returns!
Lexicon Pharmaceuticals has performed better than Corvus Pharmaceuticals in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!
Biotelemetry Inc has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 230.87% more returns!
Aclaris Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 21.41% more returns!
Lexicon Pharmaceuticals Technical analysis of indicators
Price action analysis of Lexicon Pharmaceuticals (LXRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Lexicon Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Lexicon Pharmaceuticals in short term and the sell signal is strong.
Lexicon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Lexicon Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Lexicon Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.2 and Lexicon Pharmaceuticals LXRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Lexicon Pharmaceuticals LXRX stock. Volume based technical analysis of Lexicon Pharmaceuticals LXRX stock is negative.
Lexicon Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock LXRX Lexicon Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And LXRX Experts View which covers a lot of information including buying and selling signals
LXRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Lexicon Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
